GlaxoSmithKline (Spain)
In research, GlaxoSmithKline (Spain) stands highest in Medicine (#9,650 of 17,978 worldwide) and Health Sciences (#12,444 of 20,462 worldwide), over all time.
- World rank, all time
- #15,521 of 42,892
- Rank in Spain
- #392 of 927
- Research works
- 362 ▼ 10% vs 2013–17
- Citations
- 11k 29.5 per fractional work
- Top-10% rate
- 17.5% record average 16.5%
- Open access
- 47% world 28%
What is GlaxoSmithKline (Spain) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #9,650 of 17,978 | 25.6% | 190 | |
| Health SciencesDomain | #12,444 of 20,462 | 24.9% | 200 |
Each strip is that field’s whole ranked pool, with the notch where GlaxoSmithKline (Spain) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.1×. Every wedge is a field page.
- Immunology and Microbiology 8.1×
- Chemistry 4.9×
- Pharmacology, Toxicology and Pharmaceutics 3.1×
- Biochemistry, Genetics and Molecular Biology 2.8×
- Medicine 2.7×
- Veterinary 1.9×
- Health Professions 1.1×
- Mathematics 1.0×
- Materials Science 0.9×
- Economics, Econometrics and Finance 0.5×
- Business, Management and Accounting 0.4×
- Agricultural and Biological Sciences 0.4×
- Neuroscience 0.3×
- Environmental Science 0.2×
- Computer Science 0.2×
- Arts and Humanities 0.1×
- Social Sciences 0.1×
- Engineering 0.1×
Who are the top researchers at GlaxoSmithKline (Spain)?
Ranked on the composite score, Emilio Fernández Álvarez and Francisco‐Javier Gamo lead among researchers whose main affiliation is GlaxoSmithKline (Spain).
- 1 Emilio Fernández Álvarez Spain · #348,257 worldwide 51 citations · 25 works
- 2 Francisco‐Javier Gamo Spain · #566,471 worldwide 81 citations · 15 works
Which keywords describe research at GlaxoSmithKline (Spain)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Treatment, Diagnosis, Vaccine Development, Drug Resistance, Inflammation, Immune Response and Vaccine.
- Polylactic Acid
- Biodegradable Polymers
- Tuberculosis
- Heterocyclic Compounds
- Cancer
- Antiretroviral Therapy
- Mycobacterium tuberculosis
- Plasmodium falciparum
- Chemotherapy
- Artemisinin Resistance
- Metabolism
- Immunity
- Eosinophils
- Synthesis
- Asthma
- Immunology
- Vaccine
- Drug Resistance
- Inflammation
- Treatment
- Epidemiology
- Diagnosis
- Vaccine Development
- Immune Response
- Genetics
- Pathogenesis
- Global Burden
- Allergic Diseases
- Genome Sequence
- Management
- Medicinal Chemistry
- Biological Evaluation
- Genetic Diversity
- Vector Control
- Anticancer Agents
- Biomedical Applications
- Cardiovascular Disease
- Host-Pathogen Interaction
- Antiviral Therapy
- Cancer Therapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology13▲ 7.4×37 topics
- Treatment6▲ 11×15 topics
- Diagnosis4▲ 11×14 topics
- Inflammation4▲ 4.4×15 topics
- Vaccine Development3▲ 31×7 topics
- Drug Resistance3▲ 26×5 topics
- Immune Response3▲ 12×10 topics
- Vaccine3▲ 16×7 topics
- Genetics3▲ 8.7×3 topics
- Immunology3▲ 57×2 topics
- Pathogenesis2▲ 11×11 topics
- Asthma2▲ 58×2 topics
- Global Burden2▲ 9.9×5 topics
- Synthesis2▲ 14×7 topics
- Allergic Diseases2▲ 88×1 topic
- Eosinophils2▲ 88×1 topic
- Genome Sequence2▲ 61×2 topics
- Immunity2▲ 12×6 topics
- Management2▲ 5.3×5 topics
- Metabolism2▲ 7.0×4 topics
- Medicinal Chemistry2▲ 12×5 topics
- Artemisinin Resistance1▲ 99×1 topic
- Biological Evaluation1▲ 54×3 topics
- Chemotherapy1▲ 4.5×8 topics
- Genetic Diversity1▲ 7.0×3 topics
- Plasmodium falciparum1▲ 99×1 topic
- Vector Control1▲ 26×3 topics
- Mycobacterium tuberculosis1▲ 52×2 topics
- Anticancer Agents1▲ 17×2 topics
- Antiretroviral Therapy1▲ 16×6 topics
- Biomedical Applications1▲ 2.2×3 topics
- Cancer1▲ 1.82×8 topics
- Cardiovascular Disease1▲ 2.3×5 topics
- Heterocyclic Compounds1▲ 30×2 topics
- Host-Pathogen Interaction1▲ 36×1 topic
- Tuberculosis1▲ 50×1 topic
- Antiviral Therapy1▲ 24×3 topics
- Biodegradable Polymers1▲ 14×1 topic
- Cancer Therapy1▲ 4.2×4 topics
- Polylactic Acid1▲ 30×1 topic
Which research topics does GlaxoSmithKline (Spain) publish most on?
By volume in 2022–2025: Asthma and respiratory diseases, Malaria Research and Control, Tuberculosis Research and Epidemiology and biodegradable polymer synthesis and properties.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Asthma and respiratory diseases Physiology 2 works
- 2 Malaria Research and Control Public Health, Environmental and Occupational Health 1 works
- 3 Tuberculosis Research and Epidemiology Infectious Diseases 1 works
- 4 biodegradable polymer synthesis and properties Biomaterials 1 works
- 5 Trypanosoma species research and implications Epidemiology 1 works
- 6 Research on Leishmaniasis Studies Public Health, Environmental and Occupational Health 1 works
- 7 Biochemical and Molecular Research Molecular Biology 1 works
- 8 Synthesis of heterocyclic compounds Organic Chemistry 1 works
- 9 Synthesis and biological activity Organic Chemistry 1 works
- 10 Pediatric health and respiratory diseases Emergency Medical Services 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has GlaxoSmithKline (Spain)'s research output changed?
Output in 2018–2022 was 10% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Madrid
- Universidad Complutense de Madrid
- Universidad Autónoma de Madrid
- Universidad Politécnica de Madrid
- Consejo Superior de Investigaciones Científicas
- Universidad Carlos III de Madrid
- Universidad Rey Juan Carlos
- Universidad Nacional de Educación a Distancia
- Hospital Universitario La Paz
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.